The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

Saliva-Based RNA Panel Accurately Distinguishes Children with Autism Spectrum Disorder from Non-Autistic Peers
Gut-Brain Axis

Saliva-Based RNA Panel Accurately Distinguishes Children with Autism Spectrum Disorder from Non-Autistic Peers

NOV 13, 2018
4D Pharma plc Announces First Patient Enrolment in Blautix IBS Phase II study
Clinical & Manufacturing

4D Pharma plc Announces First Patient Enrolment in Blautix IBS Phase II study

NOV 9, 2018
Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate
Oncology

Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate

NOV 6, 2018
OxThera Presents Encouraging 52-Week Efficacy and Safety Data for Oxabact® in Primary Hyperoxaluria Type 1 (PH1) Patients with ESRD
Pharma & Human Health

OxThera Presents Encouraging 52-Week Efficacy and Safety Data for Oxabact® in Primary Hyperoxaluria Type 1 (PH1) Patients with ESRD

OCT 31, 2018
Researchers Identify Three Distinct Stages in Infant Microbiome Development
Editor's Choice

Researchers Identify Three Distinct Stages in Infant Microbiome Development

OCT 26, 2018
Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital™ Fund
Finance

Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital™ Fund

OCT 25, 2018
ConsortiaTX Awarded Exclusive License for Food Allergy Microbial Therapy
Pharma & Human Health

ConsortiaTX Awarded Exclusive License for Food Allergy Microbial Therapy

OCT 24, 2018
Gut Bacteria May Play Role in Heart Attack Recovery
Animal Health

Gut Bacteria May Play Role in Heart Attack Recovery

OCT 24, 2018
Enterome Signs Global Licensing, Co-development and Co-promotion Agreement with Takeda for the Treatment of Crohn’s Disease
Finance

Enterome Signs Global Licensing, Co-development and Co-promotion Agreement with Takeda for the Treatment of Crohn’s Disease

OCT 23, 2018
Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Tool for Clinical Development
Gastrointestinal

Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Tool for Clinical Development

OCT 22, 2018
Symberix Announces Non-Dilutive Funding Support for Lead Programs
Finance

Symberix Announces Non-Dilutive Funding Support for Lead Programs

OCT 22, 2018